Codex DNA (TBIO) - Market Cap to Earnings

Telesis Bio, Inc - graphic logo of issuer TBIO

The daily price chart for Telesis Bio, Inc. (TBIO) serves as an indicator for a business attracting microfluidics experts to develop DNA printers. This scientific and technical synergy fuels the release of updated mRNA vaccine cartridges via the BioXp platform. The metric stands at -0.10. Market capitalization relies on the sale of automated synthesizers and regular supplies of chemical components for biolabs.

Telesis Bio (TBIO) P/E Multiple: for the period 04/28/2023 - 10/05/2024

Analytical breakdowns for Codex DNA (TBIO)

- stock quotes and analyst forecast:
Price Chart telesisbio.com|TBIO - Analyst Consensus Forecast
- market capitalization indicators:
Market Value Telesis Bio, Inc.|TBIO - Total Company Value
- book value of equity indicators:
Net Assets per Share Telesis Bio|TBIO - Book Capitalization|Market Capitalization to Book Value telesisbio.com|TBIO - Aggregate Company Assets
- company liabilities and liquidity data:
Total Debt to Capital Coefficient Telesis Bio, Inc.|TBIO - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Telesis Bio, Inc|TBIO - Company Aggregate Debts|Debt to Book Capitalization Ratio Telesis Bio, Inc.|TBIO - Company Long-Term Debts|Short-Term Debt Volume Telesis Bio|Immediate Liquidity telesisbio.com
- earnings and market multiples details:
TBIO - Net Income|Expected Net Income Telesis Bio, Inc.|TBIO - P/E Multiple|Market Cap to Projected Earnings Telesis Bio Inc.|TBIO - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Telesis Bio, Inc.|TBIO - Operating profit EBITDA|Net earnings per share for the last 12 months Telesis Bio|TBIO - Net earnings per share for the last 12 months|Year-over-year net earnings per share change for the last twelve months telesisbio.com|TBIO - Net earnings per share growth this year|Projected earnings per share increase next year Telesis Bio, Inc.
Summary company analysis:telesisbio.com
Manufactured product of Telesis Bio, Inc

For Telesis Bio, Inc., a supplier of nucleic acid synthesis systems, the P/E ratio serves as a tool for assessing market value relative to net income. This multiple determines the capital payback period by comparing market capitalization with actual financial results. By analyzing changes in the company's P/E, an investor can see the impact of equipment and consumables sales on the share price. The indicator's trend reveals the efficiency of monetizing biotechnological developments, while a stable ratio confirms the fundamental resilience of the business model.

Key competitors

Price to Earnings Ratio TEM|P/E Multiple QGEN|IONS - Market Cap to Earnings|Price to Earnings Ratio Repligen Corp. RGEN|Business Payback Period Avidity Corp (RNA)|CRISPR Therapeutics AG - P/E Multiple|Business Payback Period genedx.com WGS|Ultragenyx (RARE) - Price to Earnings Ratio|BEAM - Business Payback Period|Price to Earnings Ratio SRPT|TWST: Company Value to Net Income|P/E Multiple TXG|Price to Earnings Ratio NTLA (intelliatx.com)|P/E Multiple STOK (Stoke Therapeutics, Inc.)|Business Payback Period BioLife Solutions Inc (BLFS)|WVE - Price to Earnings Ratio|Market Cap to Earnings Maze Therapeutics Corp|SION (Sionna Therapeutics Inc) - Price to Earnings Ratio|primemedicine.com - Company Value to Net Income|TSHA (Taysha Gene Therapies, Inc.) - P/E Multiple|uniQure NV (QURE) - Business Payback Period|Price to Earnings Ratio MeiraGTx PLC (MGTX)|REGENXBIO Corp - Price to Earnings Multiple|P/E Multiple SLDB (Solid Biosciences Inc.)|OCGN - Price to Earnings Ratio|PACB: Price to Earnings Ratio|Business Payback Period Benitec Biopharma Inc BNTC|DSGN (Design Pharma) - Price to Earnings Ratio|RCKT: Market Price to Net Income Ratio|FDMT (4D Molecular Therapeutics) - P/E Multiple|Price to Earnings Ratio LXEO|P/E Multiple KRRO|Business Payback Period Editas Medicine Inc|Price to Earnings Ratio Silence Therapeutics Inc. SLN|ProQR (PRQR) - Market Cap to Earnings|Codexis Bio - P/E Multiple|SGMO (sangamo.com) - Price to Earnings Multiple|nautilus.bio (NAUT) - Price to Earnings Ratio|Price to Earnings Multiple MGX|DTIL (Precision BioSciences, Inc.) - P/E Multiple|P/E Multiple Generation Bio Corp|Price to Earnings Ratio BOLD (Boundless Bio, Inc.)|Market Price to Net Income Ratio XCUR|P/E Multiple IMNN (Imunon)|Phio Pharmaceuticals Corp (PHIO) - Market Cap to Earnings|MBIO - Price to Earnings Ratio|RNAZ: Price to Earnings Ratio|BNGO: P/E Multiple|Market Cap to Earnings adnas.com (APDN)|Price to Earnings Ratio bluebird bio|ImmunoPrecise (IPA) - Business Payback Period|P/E Multiple OMGA|Business Payback Period Singular Genomics Corp|Price to Earnings Ratio Regulus Therapeutics RGLS|Business Payback Period syros.com (SYRS)|TCON: Price to Earnings Ratio|Company Value to Net Income UBX (Unity Biotechnology Inc.)